Tania Armstrong-Whitworth
Stock Analyst at Canaccord Genuity
(3.78)
# 2,013
Out of 4,698 analysts
152
Total ratings
44.4%
Success rate
6.5%
Average return
Main Sectors:
Stocks Rated by Tania Armstrong-Whitworth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSXV: NURS Hydreight Technologies Inc. | Maintained: Buy | $6.75 | $3.71 | +81.94% | 1 | Sep 2, 2026 | |
| TSXV: DMGI DMG Blockchain Solutions Inc. | Downgraded: Hold | $0.40 → $0.55 | $0.54 | +1.85% | 5 | Aug 27, 2026 | |
| TSX: JWEL Jamieson Wellness Inc. | Downgraded: Hold | $43.50 → $45.75 | $45.41 | +0.75% | 17 | Aug 10, 2026 | |
| TSX: APTX Apotex Health Corp. | Initiated Coverage: Buy | $42.00 | $33.02 | +27.20% | 1 | Jul 13, 2026 | |
| TSX: MSCL Satellos Bioscience Inc. | Initiated Coverage: Buy | $1.25 → $19.00 | $12.53 | +51.64% | 5 | May 21, 2026 | |
| TSX: HLS HLS Therapeutics Inc. | Initiated Coverage: Hold | $4.00 → $5.00 | $3.60 | +38.89% | 20 | May 19, 2026 | |
| TSX: GUD Knight Therapeutics Inc. | Initiated Coverage: Buy | $7.50 → $9.50 | $10.04 | -5.38% | 23 | May 8, 2026 | |
| TSX: EXE Extendicare Inc. | Maintained: Buy | $13.00 → $22.50 | $31.16 | -27.79% | 2 | Dec 4, 2025 | |
| TSXV: BTCT Bitcoin Treasury Corporation | Maintained: Buy | $13.50 → $12.25 | $3.85 | +218.18% | 3 | Nov 14, 2025 | |
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Maintained: Buy | $9.00 | $10.36 | n/a | 5 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13.00 → $14.00 | $14.39 | n/a | 4 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18.00 → $19.50 | $17.46 | n/a | 4 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.25 → $3.50 | $3.25 | n/a | 8 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.00 → $2.65 | $5.10 | n/a | 18 | Jul 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.4 → $0.33 | $0.1823 | n/a | 10 | Nov 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $18 | $38.00 | n/a | 12 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Buy | $3.50 → $3.00 | $1.55 | n/a | 14 | Jun 28, 2022 |
Hydreight Technologies Inc.
Sep 2, 2026
Maintained: Buy
Price Target: $6.75
Current: $3.71
Upside: +81.94%
DMG Blockchain Solutions Inc.
Aug 27, 2026
Downgraded: Hold
Price Target: $0.40 → $0.55
Current: $0.54
Upside: +1.85%
Jamieson Wellness Inc.
Aug 10, 2026
Downgraded: Hold
Price Target: $43.50 → $45.75
Current: $45.41
Upside: +0.75%
Apotex Health Corp.
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $42.00
Current: $33.02
Upside: +27.20%
Satellos Bioscience Inc.
May 21, 2026
Initiated Coverage: Buy
Price Target: $1.25 → $19.00
Current: $12.53
Upside: +51.64%
HLS Therapeutics Inc.
May 19, 2026
Initiated Coverage: Hold
Price Target: $4.00 → $5.00
Current: $3.60
Upside: +38.89%
Knight Therapeutics Inc.
May 8, 2026
Initiated Coverage: Buy
Price Target: $7.50 → $9.50
Current: $10.04
Upside: -5.38%
Extendicare Inc.
Dec 4, 2025
Maintained: Buy
Price Target: $13.00 → $22.50
Current: $31.16
Upside: -27.79%
Bitcoin Treasury Corporation
Nov 14, 2025
Maintained: Buy
Price Target: $13.50 → $12.25
Current: $3.85
Upside: +218.18%
Eupraxia Pharmaceuticals Inc.
Sep 2, 2025
Maintained: Buy
Price Target: $9.00
Current: $10.36
Upside: n/a
Aug 11, 2025
Maintained: Hold
Price Target: $13.00 → $14.00
Current: $14.39
Upside: n/a
Nov 5, 2024
Maintained: Buy
Price Target: $18.00 → $19.50
Current: $17.46
Upside: n/a
Aug 8, 2024
Maintained: Buy
Price Target: $4.25 → $3.50
Current: $3.25
Upside: n/a
Jul 4, 2024
Maintained: Buy
Price Target: $3.00 → $2.65
Current: $5.10
Upside: n/a
Nov 15, 2023
Maintained: Hold
Price Target: $0.4 → $0.33
Current: $0.1823
Upside: n/a
Nov 21, 2022
Maintained: Buy
Price Target: $22 → $18
Current: $38.00
Upside: n/a
Jun 28, 2022
Downgraded: Buy
Price Target: $3.50 → $3.00
Current: $1.55
Upside: n/a